degarelix Articles
Lower risk of CV Events or deaths in prostate cancer patients treated with degarelix compared to LHRH agonists
18 March 2013
In Japan, Celgene’s Revlimid gets approval; Astellas to file degarelix and inks vaccine deal with UMN
23 August 2010
Showing 1-3 of 3 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
